About Kalysta Pharmaceuticals Private Limited
Data last updated:
Kalysta Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2014PTC260190. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anandvivek Bajpai and Shailendra Kumar Dubey.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Office No. L – 42 Dreams – The Mall Lbs Road Bhandup West, Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2018, the company reported a revenue of ₹15.06 Lakh. For the same year it recorded a net loss of ₹4.47 Lakh (net margin -29.7%) and EBITDA of -₹3.88 Lakh (EBITDA margin -25.7%).
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website kalystapharma.com.
Company details
Contact details
Kalysta Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is kalystapharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressOffice No. L – 42 Dreams – The Mall Lbs Road Bhandup West, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kalysta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kalysta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kalysta Pharmaceuticals Private Limited, buy the company report.
Financials of Kalysta Pharmaceuticals Private Limited
FY 2019 filings availableKalysta Pharmaceuticals Private Limited reported revenue of ₹15.06 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹15.06 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.88 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹4.47 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -25.7% | |||
| Net Profit Margin | -29.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kalysta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kalysta Pharmaceuticals Private Limited
Kalysta Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anandvivek Bajpai Also directs: Paris-Dakner Nanolifesciences Private Limited | Director | 16 Dec 2014 | 11 Years 10 Months | Current |
| Shailendra Kumar Dubey | Director | 16 Dec 2014 | 11 Years 10 Months | Current |
| Gaytri Arun Singh | Director | 16 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Kalysta Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bluefinch Pharmaceuticals Private Limited | ₹15.09 Lakh (FY 2025) | -3.0% | Kolkata, West Bengal, India | |||
| Moon Rock Pharmaceuticals Private Limited | ₹15.08 Lakh (FY 2025) | 21.0% | Jind, Haryana, India | |||
| Kalysta Pharmaceuticals Private Limitedthis company | ₹15.06 Lakh (FY 2018) | -₹4.47 Lakh | -29.7% | Mumbai, Maharashtra, India | ||
| Stattlich Pharmaceuticals Private Limited | ₹15.03 Lakh (FY 2021) | -8.0% | Amravati, Maharashtra, India |
To see the full peer comparison of Kalysta Pharmaceuticals Private Limited, buy the company report.
Auditor
Kalysta Pharmaceuticals Private Limited is audited by NAVIN SHARMA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAVIN SHARMA & ASSOCIATES | FY 2018 | 130794W |
Shareholding
The shareholding of Kalysta Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kalysta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kalysta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kalysta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kalysta Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Kalysta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kalysta Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Rishikesh Akhilesh Mishra ceased to be Director on 22 Apr 2019.
Frequently asked questions
Kalysta Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2014 (12+ years old) and is registered under CIN U24230MH2014PTC260190.
Kalysta Pharmaceuticals has 3 current directors:
- Anandvivek Bajpai - Director
- Shailendra Kumar Dubey - Director
- Gaytri Arun Singh - Director
The latest financial statements of Kalysta Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Kalysta Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Kalysta Pharmaceuticals is U24230MH2014PTC260190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kalysta Pharmaceuticals was incorporated on 16 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kalysta Pharmaceuticals by revenue are Bluefinch Pharmaceuticals Private Limited, Moon Rock Pharmaceuticals Private Limited, Stattlich Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rishikesh Akhilesh Mishra ceased to be Director on 22 Apr 2019. Anandvivek Bajpai was appointed as Director on 16 Dec 2014. Gaytri Arun Singh was appointed as Director on 16 Dec 2014. Kalysta Pharmaceuticals has 4 board changes on record in total.
Kalysta Pharmaceuticals can be reached through the website kalystapharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Kalysta Pharmaceuticals is at Office No. L – 42 Dreams – The Mall Lbs Road Bhandup West, Mumbai, Maharashtra, India – 400078.
Kalysta Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.